Designing Modulators of Monoamine Transporters using Virtual Screening Techniques

The plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their respective monoamine neurotransmitters. The transporters are th...

Full description

Bibliographic Details
Main Authors: Ole Valente Mortensen, Sandhya eKortagere
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00223/full
id doaj-5895fc72e4dc4c89a4bb3253011b0123
record_format Article
spelling doaj-5895fc72e4dc4c89a4bb3253011b01232020-11-24T22:54:28ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122015-09-01610.3389/fphar.2015.00223158990Designing Modulators of Monoamine Transporters using Virtual Screening TechniquesOle Valente Mortensen0Sandhya eKortagere1Drexel University College of MedicineDrexel University College of MedicineThe plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their respective monoamine neurotransmitters. The transporters are the main target of clinically used psychostimulants and antidepressants. Despite the availability of several potent and selective MAT substrates and inhibitors the continuing need for therapeutic drugs to treat brain disorders involving aberrant monoamine signaling provides a compelling reason to identify novel ways of targeting and modulating the MATs. Designing novel modulators of MAT function have been limited by the lack of three dimensional structure information of the individual MATs. However, crystal structures of LeuT, a bacterial homologue of MATs, in a substrate-bound occluded, substrate-free outward-open, and an apo inward-open state and also with competitive and noncompetitive inhibitors have been determined. In addition, several structures of the drosophila DAT have also been resolved. Together with computational modeling and experimental data gathered over the past decade, these structures have dramatically advanced our understanding of several aspects of SERT, NET, and DAT transporter function, including some of the molecular determinants of ligand interaction at orthosteric substrate and inhibitor binding pockets. In addition progress has been made in the understanding of how allosteric modulation of MAT function can be achieved. Here we will review all the efforts up to date that has been made through computational approaches employing structural models of MATs to design small molecule modulators to the orthosteric and allosteric sites using virtual screening techniques.http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00223/fullserotonin transporterModeling and simulationsVirtual Screeningmonoamine transportersdopamine transporternorepinephrine transporter
collection DOAJ
language English
format Article
sources DOAJ
author Ole Valente Mortensen
Sandhya eKortagere
spellingShingle Ole Valente Mortensen
Sandhya eKortagere
Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
Frontiers in Pharmacology
serotonin transporter
Modeling and simulations
Virtual Screening
monoamine transporters
dopamine transporter
norepinephrine transporter
author_facet Ole Valente Mortensen
Sandhya eKortagere
author_sort Ole Valente Mortensen
title Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
title_short Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
title_full Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
title_fullStr Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
title_full_unstemmed Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
title_sort designing modulators of monoamine transporters using virtual screening techniques
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2015-09-01
description The plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their respective monoamine neurotransmitters. The transporters are the main target of clinically used psychostimulants and antidepressants. Despite the availability of several potent and selective MAT substrates and inhibitors the continuing need for therapeutic drugs to treat brain disorders involving aberrant monoamine signaling provides a compelling reason to identify novel ways of targeting and modulating the MATs. Designing novel modulators of MAT function have been limited by the lack of three dimensional structure information of the individual MATs. However, crystal structures of LeuT, a bacterial homologue of MATs, in a substrate-bound occluded, substrate-free outward-open, and an apo inward-open state and also with competitive and noncompetitive inhibitors have been determined. In addition, several structures of the drosophila DAT have also been resolved. Together with computational modeling and experimental data gathered over the past decade, these structures have dramatically advanced our understanding of several aspects of SERT, NET, and DAT transporter function, including some of the molecular determinants of ligand interaction at orthosteric substrate and inhibitor binding pockets. In addition progress has been made in the understanding of how allosteric modulation of MAT function can be achieved. Here we will review all the efforts up to date that has been made through computational approaches employing structural models of MATs to design small molecule modulators to the orthosteric and allosteric sites using virtual screening techniques.
topic serotonin transporter
Modeling and simulations
Virtual Screening
monoamine transporters
dopamine transporter
norepinephrine transporter
url http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00223/full
work_keys_str_mv AT olevalentemortensen designingmodulatorsofmonoaminetransportersusingvirtualscreeningtechniques
AT sandhyaekortagere designingmodulatorsofmonoaminetransportersusingvirtualscreeningtechniques
_version_ 1725659700380303360